PALM SPRINGS, Calif. (KESQ) -The CDC says prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. With prostate cancer cases on the rise across the nation ...
Morning Overview on MSN
New prostate cancer immunotherapy slashes biomarkers by up to 99%
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...
The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...
Hosted on MSN
Prostate cancer is the second deadliest form of cancer in men. SC lawmakers want more men to get screened.
Prostate cancer is the second leading cause of cancer deaths in men, according to the South Carolina Department of Public Health. Now, a special legislative committee is exploring ways to detect it ...
Can AI match radiologists in prostate MRI diagnosis? The PARADIGM trial will assess AI detection of clinically significant ...
It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results